61 related articles for article (PubMed ID: 35405782)
41. Advances in adult acute lymphoblastic leukemia therapy.
Aldoss I; Stein AS
Leuk Lymphoma; 2018 May; 59(5):1033-1050. PubMed ID: 28745565
[TBL] [Abstract][Full Text] [Related]
42. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
[TBL] [Abstract][Full Text] [Related]
43. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
Dhédin N; Huynh A; Maury S; Tabrizi R; Beldjord K; Asnafi V; Thomas X; Chevallier P; Nguyen S; Coiteux V; Bourhis JH; Hichri Y; Escoffre-Barbe M; Reman O; Graux C; Chalandon Y; Blaise D; Schanz U; Lhéritier V; Cahn JY; Dombret H; Ifrah N;
Blood; 2015 Apr; 125(16):2486-96; quiz 2586. PubMed ID: 25587040
[TBL] [Abstract][Full Text] [Related]
44. The IKAROS interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis.
Bottardi S; Mavoungou L; Pak H; Daou S; Bourgoin V; Lakehal YA; Affar el B; Milot E
PLoS Genet; 2014 Dec; 10(12):e1004827. PubMed ID: 25474253
[TBL] [Abstract][Full Text] [Related]
45. Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.
Caye A; Beldjord K; Mass-Malo K; Drunat S; Soulier J; Gandemer V; Baruchel A; Bertrand Y; Cavé H; Clappier E
Haematologica; 2013 Apr; 98(4):597-601. PubMed ID: 23065506
[TBL] [Abstract][Full Text] [Related]
46. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.
Popescu M; Gurel Z; Ronni T; Song C; Hung KY; Payne KJ; Dovat S
J Biol Chem; 2009 May; 284(20):13869-13880. PubMed ID: 19282287
[TBL] [Abstract][Full Text] [Related]
47. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
[TBL] [Abstract][Full Text] [Related]
48. Early hematopoietic lineage restrictions directed by Ikaros.
Yoshida T; Ng SY; Zuniga-Pflucker JC; Georgopoulos K
Nat Immunol; 2006 Apr; 7(4):382-91. PubMed ID: 16518393
[TBL] [Abstract][Full Text] [Related]
49. The Ikaros gene is required for the development of all lymphoid lineages.
Georgopoulos K; Bigby M; Wang JH; Molnar A; Wu P; Winandy S; Sharpe A
Cell; 1994 Oct; 79(1):143-56. PubMed ID: 7923373
[TBL] [Abstract][Full Text] [Related]
50. IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
Stanulla M; Cavé H; Moorman AV
Blood; 2020 Jan; 135(4):252-260. PubMed ID: 31821407
[TBL] [Abstract][Full Text] [Related]
51.
Paolino J; Tsai HK; Harris MH; Pikman Y
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255194
[No Abstract] [Full Text] [Related]
52. Prognostic significance of copy number variation in B-cell acute lymphoblastic leukemia.
Song Y; Fang Q; Mi Y
Front Oncol; 2022; 12():981036. PubMed ID: 35992882
[TBL] [Abstract][Full Text] [Related]
53. [Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia].
Tang BQ; Cai ZH; Lin DN; Wang ZX; Liang XJ; Fan ZP; Huang F; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):235-240. PubMed ID: 35405782
[No Abstract] [Full Text] [Related]
54. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
55. Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
Churchman ML; Mullighan CG
Exp Hematol; 2017 Feb; 46():1-8. PubMed ID: 27865806
[TBL] [Abstract][Full Text] [Related]
56. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
